Please try another search
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington’s disease; and ferroptosis and inflammation platforms, including vatiquinone to treat Friedreich ataxia and utreloxastat for the treatment of amyotrophic lateral sclerosis. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Michael Schmertzler | 69 | 2001 | Independent Chairman of the Board |
Alethia Rene Young | 43 | 2022 | Independent Director |
Mary L. Smith | 60 | 2021 | Independent Director |
Matthew B. Klein | 51 | 2020 | CEO & Director |
Stuart W. Peltz | 63 | 1998 | Co-Founder, Senior Consultant & Member of Scientific Advisory Board |
Allan Steven Jacobson | 77 | 1998 | Co-Founder, Chairman of Scientific Advisory Board & Independent Director |
William F. Bell | 67 | 2023 | Independent Director |
Stephanie Smith Okey | 63 | 2018 | Independent Director |
Joseph D. Puglisi | - | 2003 | Member of Scientific Advisory Board |
David P. Southwell | 63 | 2005 | Independent Director |
Jerome Bernard Zeldis | 74 | 2012 | Independent Director |
Marvin Wickens | - | - | Member of Scientific Advisory Board |
Robert J. Schneider | - | - | Member of Scientific Advisory Board |
Eric N. Jacobsen | 64 | - | Member of the Scientific Advisory Board |
Glenn Daniel Steele | 79 | 2015 | Independent Director |
Emma Reeve | 63 | 2018 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review